SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Statement re Recommended Proposals for Merger

19 Jun 2017 07:00

RNS Number : 3908I
Calculus VCT PLC
19 June 2017
Β 

CALCULUS VCT PLC - Recommended Proposals for Merger and Offer to subscribe for up to Β£5m with an over-allotment option of up to a further Β£5m

19Β June 2017

CALCULUS VCT PLC ("The Company")

NEPTUNE-CALCULUS INCOME AND GROWTH VCT PLC ("Neptune VCT")

(Together the "Companies")

Β 

TIDM: CLC, CLCC, CLCD and CLCN

Β 

RECOMMENDED PROPOSALS FOR MERGER WITH NEPTUNE VCT AND OFFER TO SUBSCRIBE FOR UP TO Β£5M WITH AN OVER ALLOTMENT OPTION OF UP TO A FURTHER Β£5M

Β 

SUMMARY

Β 

Your Board is pleased to announce that it has agreed in principle with the board of Neptune VCT to merge with the Company (the "Merger") on a relative net asset basis. Each of the Companies is managed by Calculus Capital Limited ("Calculus Capital").

Β 

Your board believes there will be significant benefits for all Shareholders arising from the proposed merger with the Neptune VCT which are set out below. The merger, which will follow the methodology used in the majority of VCT mergers, will be effected by means of placing Neptune VCT into members' voluntary liquidation pursuant to Section 110 of IA 1986 and the acquisition by the Company of all of Neptune VCT's assets and liabilities in consideration for the issue of Consideration Shares, forming an enlarged VCT (the "Enlarged Company").

Β 

The Merger will be conditional upon certain conditions being satisfied which will be set out in the circulars to be posted in due course to the Companies' respective shareholders together with a prospectus in connection with the Merger (the "Prospectus").

Β 

Conditional upon the Merger being effected, the Company intends to seek further investment of up to Β£5 million to be allotted in the 2017/18 and 2018/19 tax years with an over-allotment option of up to a further Β£5 million (the "Offer").

If the Merger is effected, the Company should have increased net assets to in excess of Β£10 million, prior to any shares being issued in the Offer. This is net of dividends paid to date to the Ordinary and C shares of 84.05p pence and 73.10p pence per share, respectively.

BENEFITS ANTICIPATED FROM THE MERGER

The Merger should result in the following benefits for Shareholders:

Β· a reduction in the expected annual running costs for Shareholders due to operational expenses being spread over a larger base;

Β· a larger pool of distributable reserves to support future dividend payments;

Β· the opportunity for future buy backs, particularly for Shareholders who have held their shares for more than 5 years; and

Β· exposure to a more diversified portfolio.

Additional attractive features of the Merger include:

Β· the Company's venture capital investment manager, Calculus Capital has agreed to contribute 33% of the costs of the Merger, meaning that the costs will be split evenly between Calculus Capital, the Company and Neptune VCT;

Β· no impact on the tax position of Shareholders, and

Β· existing VCT tax reliefs carry over and attach to the post-Merger shares for Shareholders and shareholders in Neptune VCT.

A reduction in the expected annual running costs

Β 

Subject to the Merger taking place, Calculus Capital has agreed to increase its potential contribution to the running costs of the Company by reducing the cost cap (excluding irrecoverable VAT, annual trail commission and performance incentive fees) from 3% of the gross amount raised under the ordinary and C Share offers and 3.4% of the gross amount raised under the D Share offers to 3% of the net assets of the Enlarged Company at each financial year end.

THE COMPANY BOARD

It is proposed that, if the Merger is approved, the Board of the Company should be:

Β· Michael O'Higgins;

Β· Arthur John Glencross;

Β· Kate Cornish-Bowden;

Β· Steven Meeks; and

Β· Diane Seymour-Williams.

TIMETABLE

It was announced in the Company's Report and Accounts on 12 May 2017, that the merger of the Company's Ordinary, C and D Share classes was expected to take place on a date as soon as possible after 30 May 2017 when HMRC clearance for the share class merger is received. HMRC clearance is expected imminently and it is expected that that the share class merger will take place as soon as possible thereafter.

Following the merger of the share classes, it is expected that shareholder circulars seeking approval for the Merger and other related matters, together with the Prospectus, will be posted to the shareholders of the Company and Neptune VCT as soon as possible thereafter.

Subject to shareholders' approvals, it is expected that the Merger of the Companies can be completed within 6 weeks of the date of posting.

Calculus Capital Limited

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRMMGMVVVGGNZM
Date   Source Headline
22nd Apr 20263:39 pmRNSTransaction in Own Shares
31st Mar 20265:55 pmRNSDirectorate change
25th Mar 20262:23 pmRNSIssue of Equity
18th Feb 20263:14 pmRNSIssue of Equity
22nd Jan 20269:29 amRNSTransaction in Own Shares
16th Jan 20264:34 pmRNSNet Asset Value(s)
14th Jan 20263:00 pmRNSDividend Declaration
18th Dec 20252:30 pmRNSIssue of Equity
18th Dec 20252:30 pmRNSIssue of Equity
17th Dec 20253:15 pmRNSIssue of Equity
15th Dec 20253:10 pmRNSHalf-year Financial Report
14th Oct 20254:33 pmRNSTransaction in Own Shares
3rd Oct 202511:42 amRNSPublication of a Prospectus
2nd Oct 20254:29 pmRNSIssue of Equity
24th Sep 202511:22 amRNSResult of AGM & Change in Directorship
2nd Sep 20252:48 pmRNSIssue of Equity
28th Aug 202512:38 pmRNSPublication of Supplementary Prospectus
27th Aug 20252:52 pmRNSNet Asset Value
31st Jul 20259:46 amRNSAnnual Report with updated dividend details
30th Jul 202511:31 amRNSAnnual Financial Report &Related Party Transaction
3rd Jul 20259:17 amRNSIssue of Equity
10th Jun 20254:41 pmRNSTransaction in Own Shares
5th Jun 20254:39 pmRNSTransaction in Own Shares
4th Apr 20255:15 pmRNSIssue of Equity
26th Mar 20253:21 pmRNSIssue of Equity
11th Mar 20255:11 pmRNSChange of auditor
20th Feb 20254:30 pmRNSIssue of Equity
12th Feb 20254:39 pmRNSTransaction in Own Shares
21st Jan 20255:11 pmRNSNet Asset Value(s)
10th Jan 20253:46 pmRNSIssue of Equity update
18th Dec 20244:24 pmRNSIssue of Equity - 18 December 2024
5th Dec 20245:25 pmRNSHalf-year Report
14th Oct 20241:40 pmRNSPublication of a Prospectus
8th Oct 20245:23 pmRNSTransaction in Own Shares
9th Sep 202411:48 amRNSStatement re Intention to Fund Raise
29th Aug 20245:32 pmRNSIssue of Equity
22nd Aug 20244:27 pmRNSResults of Annual General Meeting
31st Jul 20245:44 pmRNSIssue of Equity
17th Jul 20241:51 pmRNSNet Asset Value(s)
11th Jul 20245:38 pmRNSAnnual Financial Report
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.